
Maris R. Kessel
Examiner (ID: 14775, Phone: (571)270-7698 , Office: P/1759 )
| Most Active Art Unit | 1759 |
| Art Unit(s) | 1795, 1759, 1758, 1699 |
| Total Applications | 485 |
| Issued Applications | 239 |
| Pending Applications | 11 |
| Abandoned Applications | 232 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11946194
[patent_doc_number] => 20170250345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'ORGANIC SEMICONDUCTOR ELEMENT, MANUFACTURING METHOD THEREOF, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, COMPOUND, AND OLIGOMER OR POLYMER'
[patent_app_type] => utility
[patent_app_number] => 15/593337
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17158
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15593337
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/593337 | Organic semiconductor element, manufacturing method thereof, organic semiconductor composition, organic semiconductor film, compound, and oligomer or polymer | May 11, 2017 | Issued |
Array
(
[id] => 16756473
[patent_doc_number] => 10975009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Selective reduction of aldehydes and ketones
[patent_app_type] => utility
[patent_app_number] => 16/300944
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8933
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300944 | Selective reduction of aldehydes and ketones | May 10, 2017 | Issued |
Array
(
[id] => 16642085
[patent_doc_number] => 10919921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => P-chiral phosphine ligands and use thereof for asymmetric synthesis
[patent_app_type] => utility
[patent_app_number] => 16/099324
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22046
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 948
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099324 | P-chiral phosphine ligands and use thereof for asymmetric synthesis | May 4, 2017 | Issued |
Array
(
[id] => 14306205
[patent_doc_number] => 20190142806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/098950
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098950 | Modulators of the integrated stress pathway | May 4, 2017 | Issued |
Array
(
[id] => 14388307
[patent_doc_number] => 10307411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Use of cotinine in treating or preventing neurogenesis deficits and enhancing neurogenesis
[patent_app_type] => utility
[patent_app_number] => 15/583937
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 19243
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583937
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/583937 | Use of cotinine in treating or preventing neurogenesis deficits and enhancing neurogenesis | Apr 30, 2017 | Issued |
Array
(
[id] => 11993896
[patent_doc_number] => 20170298051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'ACTIVATOR OF ADIPONECTIN RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 15/581252
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 159
[patent_figures_cnt] => 159
[patent_no_of_words] => 28891
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581252
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581252 | ACTIVATOR OF ADIPONECTIN RECEPTOR | Apr 27, 2017 | Abandoned |
Array
(
[id] => 15200749
[patent_doc_number] => 10497881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Organic semiconductor element, manufacturing method thereof, composition for forming organic semiconductor film, compound, and organic semiconductor film
[patent_app_type] => utility
[patent_app_number] => 15/497239
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 20475
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 349
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15497239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/497239 | Organic semiconductor element, manufacturing method thereof, composition for forming organic semiconductor film, compound, and organic semiconductor film | Apr 25, 2017 | Issued |
Array
(
[id] => 14929715
[patent_doc_number] => 20190300495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => NONIONIC SURFACTANT
[patent_app_type] => utility
[patent_app_number] => 16/308105
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308105 | Nonionic surfactant | Apr 20, 2017 | Issued |
Array
(
[id] => 16476180
[patent_doc_number] => 10851108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Substituted bicyclic heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 16/094288
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28960
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 463
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094288
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094288 | Substituted bicyclic heterocyclic compounds | Apr 18, 2017 | Issued |
Array
(
[id] => 16756483
[patent_doc_number] => 10975019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Inhibitors of meprin a and b
[patent_app_type] => utility
[patent_app_number] => 16/094460
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14062
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094460 | Inhibitors of meprin a and b | Apr 17, 2017 | Issued |
Array
(
[id] => 16704321
[patent_doc_number] => 10954241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Heterocyclic compounds as ret kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/093854
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38427
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093854 | Heterocyclic compounds as ret kinase inhibitors | Apr 17, 2017 | Issued |
Array
(
[id] => 17043750
[patent_doc_number] => 11096909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Compounds for use in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 16/091551
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6535
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091551 | Compounds for use in the treatment of cancer | Apr 5, 2017 | Issued |
Array
(
[id] => 11757222
[patent_doc_number] => 20170204091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'TRICYCLIC SPACER SYSTEMS FOR NONLINEAR DEVICES'
[patent_app_type] => utility
[patent_app_number] => 15/477748
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5174
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477748
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/477748 | TRICYCLIC SPACER SYSTEMS FOR NONLINEAR DEVICES | Apr 2, 2017 | Abandoned |
Array
(
[id] => 11755987
[patent_doc_number] => 20170202854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'Method for Treatment of Primary Hormone Resistant Endometrial and Breast Cancers'
[patent_app_type] => utility
[patent_app_number] => 15/476602
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17263
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476602 | Method for Treatment of Primary Hormone Resistant Endometrial and Breast Cancers | Mar 30, 2017 | Abandoned |
Array
(
[id] => 14043343
[patent_doc_number] => 20190077778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => METHOD FOR PRODUCING ETHYLENE OXIDE
[patent_app_type] => utility
[patent_app_number] => 16/088748
[patent_app_country] => US
[patent_app_date] => 2017-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088748 | Method for producing ethylene oxide | Mar 29, 2017 | Issued |
Array
(
[id] => 15363471
[patent_doc_number] => 20200017500
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-01-16
[patent_title] => NOVEL CO-CRYSTALS
[patent_app_type] => utility
[patent_app_number] => 16/090152
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090152 | Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3',4':4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide | Mar 27, 2017 | Issued |
Array
(
[id] => 15363471
[patent_doc_number] => 20200017500
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-01-16
[patent_title] => NOVEL CO-CRYSTALS
[patent_app_type] => utility
[patent_app_number] => 16/090152
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090152 | Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3',4':4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide | Mar 27, 2017 | Issued |
Array
(
[id] => 16893455
[patent_doc_number] => 11034991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Methods to determine KDM1A target engagement and chemoprobes useful therefor
[patent_app_type] => utility
[patent_app_number] => 16/085024
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 43327
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085024
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085024 | Methods to determine KDM1A target engagement and chemoprobes useful therefor | Mar 15, 2017 | Issued |
Array
(
[id] => 14043347
[patent_doc_number] => 20190077780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => Method for Preparing Halohydrin and Epoxide
[patent_app_type] => utility
[patent_app_number] => 16/085054
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085054
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085054 | Method for Preparing Halohydrin and Epoxide | Mar 12, 2017 | Abandoned |
Array
(
[id] => 14817147
[patent_doc_number] => 10405553
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-09-10
[patent_title] => Antimicrobial articles and compounds therefor
[patent_app_type] => utility
[patent_app_number] => 15/453108
[patent_app_country] => US
[patent_app_date] => 2017-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10504
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15453108
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/453108 | Antimicrobial articles and compounds therefor | Mar 7, 2017 | Issued |